Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)

Investigation of adverse effects of oral voriconazole in the treatment of fungal infection using The FDA Adverse Event Reporting System (FAERS)

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Sonraí bibleagrafaíochta
Príomhchruthaitheoir:	Onanna, Kazi
Rannpháirtithe:	Talukder, Mesbah
Formáid:	Tráchtas
Teanga:	English
Foilsithe / Cruthaithe:	Brac University 2024
Ábhair:	Food and Drug Administration Adverse Event Reporting System (FAERS) Reported odds ratios (ROR) Fungal treatment Adverse reactions Pharmacovigilance Fungal Infection > Treatment
Rochtain ar líne:	http://hdl.handle.net/10361/22989

Míreanna comhchosúla

Cross-sectional survey to assess the knowledge, attitude and practice regarding adverse drug reactions of students of a private university
de réir: Islam, Tarikul
Foilsithe / Cruthaithe: (2021)

Assessment of knowledge and attitude of adverse Ddug reactions among healthcare professionals in Bangladesh
de réir: Paul, Sanjoy Kumer
Foilsithe / Cruthaithe: (2021)

Factors associated with antifungal resistance and the recent development in detection & treatment: a review
de réir: Madhuri, Srijila
Foilsithe / Cruthaithe: (2024)

Therapeutic and adverse effects of SSRIs
de réir: Rahman, Imtiazur
Foilsithe / Cruthaithe: (2018)

Application of NSAIDs in the treatment of pulmonary diseases- a comparative study of the therapeutic & the adverse impacts
de réir: Rahman, Farhana
Foilsithe / Cruthaithe: (2021)

The adverse impact on the project by facade package
de réir: BUCG
Foilsithe / Cruthaithe: (2023)

Exploration of endophytic fungi and their bioactive potential associated with Punica Granatum
de réir: Haque, S.A.M. Salman
Foilsithe / Cruthaithe: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
de réir: Bakar, Osama Bin Abu
Foilsithe / Cruthaithe: (2024)

A pharmacovigilance study on FDA approved interleukin inhibitor-associated alopecia in the treatment of psoriasis
de réir: Islam, Nahidul
Foilsithe / Cruthaithe: (2023)

Morpho-molecular identification and myco-chemical profiling of endophytic fungi isolated from Psidium Guajava
de réir: Zaima, Faizah
Foilsithe / Cruthaithe: (2023)

A short review on additional therapeutic effects and adverse effects of sedative and hypnotic drugs
de réir: Tisha, Sadia Sultana
Foilsithe / Cruthaithe: (2021)

Safety and efficacy of Ibuprofen in children: A review
de réir: Nasreen, Momtaha
Foilsithe / Cruthaithe: (2023)

Relationship between SGLT2 inhibitor use and risk of lower limb amputations: a pharmacovigilance study
de réir: Khandker, Tahia Anjum
Foilsithe / Cruthaithe: (2024)

Detecting Adverse Drug Reaction (ADR) with data mining and predicting its intensity with machine learning
de réir: Hussain, Nadib, et al.
Foilsithe / Cruthaithe: (2018)

TNF-α inhibitor-induced alopecia in psoriatic disease patients: a pharmacovigilance study
de réir: Afroza, Halima
Foilsithe / Cruthaithe: (2024)

Assessing therapeutic safety and efficacy of Pazopanib, Pembrolizumab plus Axitinib and Nivolumab plus Ipilimumab in Renal Cell Carcinoma: a systematic review and meta-analysis
de réir: Shawn, Ibna Hasan
Foilsithe / Cruthaithe: (2024)

Association of GLP-1 receptor agonists and risk of pancreatitis: a pharmacovigilance study based on FAERS database
de réir: Bishakha, Adwiza Chakraborty
Foilsithe / Cruthaithe: (2024)

Smart detection and classification of fungal disease in rice plants using image processing techniques
de réir: Rashed, Akib, et al.
Foilsithe / Cruthaithe: (2024)

Oral terbinafine-, fluconazole-, ravuconazole-, oteseconazole-induced hepatotoxicity and acute kidney injury in the treatment of onychomycosis: a pharmacovigilance study
de réir: Rahman, Towsifur
Foilsithe / Cruthaithe: (2024)

Hepatotoxicity and acute kidney injury associations with itraconazole, voriconazole and posaconazole in the treatment of Onychomycosis: pharmacovigilance study of FDA adverse event reporting system data (FAERS)
de réir: Hossain, Ragib
Foilsithe / Cruthaithe: (2024)

Mathematical modeling of health service utilization data using multiple logistic regression
de réir: Shrestha, Gauri, et al.
Foilsithe / Cruthaithe: (2012)

Bank Risk Within and Across Equilibria /
de réir: Agur, Itai
Foilsithe / Cruthaithe: (2014)

Thalidomide embryopathy in Japan /
Foilsithe / Cruthaithe: (1987)

Study on anticancer drugs approved by the FDA from 2014 to 2023
de réir: Rattry, Faria Rahman
Foilsithe / Cruthaithe: (2024)

Adversity and Justice
de réir: Ball

Coping with Adversity
de réir: Hill

A review on interrelation among post-authorisation study, regulatory action and pharmacogenetics in pharmacovigilance
de réir: Nusrat, Tanzina
Foilsithe / Cruthaithe: (2019)

Fuzzy logic: a contemporary technique in refining physicians’ prescribed total daily insulin dosage for type 2 diabetes patients
de réir: Tareq, Md. Tariqul Islam
Foilsithe / Cruthaithe: (2019)

Theory of nuclear reactions /
de réir: Sitenko, A. G. (Alekseĭ Grigorʹevich)
Foilsithe / Cruthaithe: (1990)

Current practice and approaches of immunotherapy in Cancer treatment
de réir: Khondokar, Faiza
Foilsithe / Cruthaithe: (2022)

An overview on Covid-19 and invention of its treatment by drugs
de réir: Nawer, Anika
Foilsithe / Cruthaithe: (2022)

Adversities of development : a case study of involuntary resettlement /
de réir: Rahman, Khondker Neaz
Foilsithe / Cruthaithe: (2004)

A survey on the knowledge and attitude on pharmacovigilance among the pharmacy students of different universities of Dhaka, Bangladesh
de réir: Albee, Md. Hamza
Foilsithe / Cruthaithe: (2017)

Theory of nuclear reactions /
de réir: Fr�obrich, P. (Peter)
Foilsithe / Cruthaithe: (1996)

Entrepreneurial Responses to Chronic Adversity
de réir: Shepherd
Foilsithe / Cruthaithe: (2022)

Optical Devices in Adverse Environments

Optical Fibers in Adverse Environments

Optical Systems in Adverse Environments

Optics in Adverse Environments II

Optics in Adverse Environments I